Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Thomas Demant"'
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 1, Pp 174-185 (2004)
Kinetics of apo B and apo AI were assessed in 8 patients with mixed hyperlipidemia at baseline and after 8 weeks of atorvastatin 80 mg q.d. and micronised fenofibrate 200 mg q.d. in a cross-over study. Both increased hepatic production and decreased
Externí odkaz:
https://doaj.org/article/08ed1672c6cf43fb87922a05886409e6
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 10, Pp 1596-1603 (2000)
Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion rates, conve
Externí odkaz:
https://doaj.org/article/e967d0ad94f54a31883d89cb1231c662
Autor:
Anke Pigulla, Konstantin Gröber, Thomas Demant, Martina Zogbaum, Jan Kramer, Olaf Bätz, Michael Anger
Publikováno v:
Clinical laboratory. 66(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf4268705ec9b6c758f271e66ec6fe0
https://pubmed.ncbi.nlm.nih.gov/32255297
https://pubmed.ncbi.nlm.nih.gov/32255297
In this thesis the influence of genetic factors on the apolipoprotein B metabolism in humans was investigated. The phenotype of the apolipoprotein E polymorphism was determined for normolipidaemic subjects (n = 1600). The metabolism of apolipoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72651def9515710ae5760e85f4f47f7e
https://doi.org/10.1159/000421220
https://doi.org/10.1159/000421220
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 16:215-221
Background and aim ApoE and apoC-III are important components of lipoprotein metabolism. While the function of both apoproteins is relatively well understood, little is known about the in vivo metabolism of these proteins, partly because of the lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f6174f65c5cea869e11cb03007ab67
https://doi.org/10.1016/j.numecd.2005.06.004
https://doi.org/10.1016/j.numecd.2005.06.004
Publikováno v:
Atherosclerosis. 157:325-339
Lipoprotein(a) is a risk factor for cardiovascular disease composed of an apolipoprotein B-containing lipoprotein to which a second protein, apolipoprotein(a), is attached. We investigated in seven subjects with Lp(a) levels of 39--85 mg/dl the metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4131671fc565e5d1f2746801796d5630
https://doi.org/10.1016/s0021-9150(00)00732-2
https://doi.org/10.1016/s0021-9150(00)00732-2
Autor:
Johannes R. Bogner, Michaela Schmitz, Thomas Demant, Andrea Bedynek, Gerlinde M. Michl, Ravi Walli, Frank D. Goebel, Dietrich Seidel
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 26:225-235
Background: Dyslipidemia (predominantly hypertriglyceridemia) is frequently seen in patients receiving antiretroviral combination therapy (ART). However, the underlying mechanisms and long-term risks (e.g., cardiovascular events) are still unclear. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5907ce9ddf8b423ce0e2404f4e86f07f
https://doi.org/10.1097/00126334-200103010-00004
https://doi.org/10.1097/00126334-200103010-00004
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 10, Pp 1596-1603 (2000)
Scopus-Elsevier
University of Western Australia
Scopus-Elsevier
University of Western Australia
Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion rates, conve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503f1f9de88a4d4b794dd28151bc27e6
http://www.sciencedirect.com/science/article/pii/S0022227520319921
http://www.sciencedirect.com/science/article/pii/S0022227520319921
Autor:
Thomas Demant, Dorothy Bedford, James Shepherd, Muriel J. Caslake, G. Schwertfeger, Dietrich Seidel, Andrea Bedynek, Christopher J. Packard, J.P. Stewart
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 2, Pp 305-317 (2000)
Apolipoprotein B (apoB) metabolism was investi- gated in 20 men with plasma triglyceride 0.66-2.40 mmol/l and plasma cholesterol 3.95-6.95 mmol/l. Kinetics of VLDL 1 (S f 60-400), VLDL 2 (S f 20-60), IDL (S f 12-20), and LDL (S f 0-12) apoB were anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcbab1594af7be11d1f53d9cee465c7
https://doi.org/10.1016/s0022-2275(20)32065-4
https://doi.org/10.1016/s0022-2275(20)32065-4
Autor:
Johannes R. Bogner, Frank D. Goebel, Christoph Dieterle, Oliver Herfort, Thomas Demant, Rüidiger Landgraf, Ravi Walli, Hans Rolf Jäger, Gerlinde M. Michl
Publikováno v:
AIDS. 12:F167-F173
Background: The use of protease inhibitors in the treatment of HIV-1 infection is associated with the new onset of diabetes mellitus, hyperlipidaemia and lipodystrophy. It is unclear whether these findings are coincidental or whether they reflect a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fae6cc068db429817c3d8b74ecaf5c4
https://doi.org/10.1097/00002030-199815000-00001
https://doi.org/10.1097/00002030-199815000-00001